Effects of conjugated linoleic acid on oxidative stress in rats with sucrose-induced non-alcoholic fatty liver disease

Journal of Functional Foods

Volumn 4, Issue 1, 2012, Pages 219-225

  Romero Sarmiento, Yohevet ^a   Soto Rodríguez, Ida ^b,c   Arzaba Villalba, Agustín ^a   García, Hugo Sergio ^a   Alexander Aguilera, Alfonso ^b,c  

^a INSTITUTO TECNOLÓGICO DE VERACRUZ   (Mexico)

^b UNIVERSIDAD VERACRUZANA   (Mexico)

^c Universidad Cristobal Colon   (Mexico)

Author keywords

CLA; Non alcoholic fatty liver disease; Oxidative stress

Indexed keywords

ANIMALIA; HELIANTHUS; RATTUS; RATTUS NORVEGICUS;

EID: 84857686710     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2011.10.009     Document Type: Article

References (41)

1. Acharya U.R., Mishra M., Mishra I. Status of antioxidant defense system in chromium-induced Swiss mice tissues. Environmental Toxicology and Pharmacology 2004, 17:117-123.
2. Adams L.A., Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabetic Medicine 2005, 22:1129-1133.
3. Alexander A., Hernández G., Lara M., Angulo O., Oliart R.M. Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-α in rats with sucrose-induced metabolic syndrome. Journal of Nutritional Biochemistry 2004, 15:350-357.
4. Assmann G. Lipid determinations today. Internist 1979, 20:559-564.
5. Barham D., Trinder P. An improved colour reagent for the determination of blood glucose by oxidase system. Analyst 1972, 97:142-145.
6. Bayliss H.O.B. Lipids. Theory and practice of histological techniques 1990, 215-244. Churchill Livingstone, Edinburgh. J.D. Bancroft, A. Stevens (Eds.).
7. Benjamin S., Hanhoff T., Börchers T., Spener F. An improved molecular test system for the screening of human PPAR transactivation by conjugated linoleic acid isomers and their precursor fatty acids. European Journal of Lipid Science and Technology 2005, 107:706-715.
8. Boelsterli U., Bedoucha M. Toxicological consequences of altered peroxisome proliferator-activated receptor gamma (PPAR gamma) expression in the liver: Insights from models of obesity and type 2 diabetes. Biochemical Pharmacology 2002, 63:1-10.
9. Brunt M.E. Nonalcoholic steatohepatitis: Definition and pathology. Seminars in Liver Disease 2001, 21:3-16.
10. Day C.P., James O.F. Steatohepatitis: A tale of two " hits" Gastroenterology 1998, 114:842-845.
11. Duvnjak M., Lerotić I., Barsić N., Tomasić V., Virović J.L., Velagić V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World Journal of Gastroenterology 2007, 13:4539-4550.
12. Fernandez-Checa J.C., Kaplowitz N., García-Ruíz C., Collel A. Mitochondrial glutathione: Importance and transport. Seminars in Liver Disease 1998, 18:389-401.
13. García-Ruiz C., Colell A., Morales A., Kaplowitz N., Fernandez-Checa J.C. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: Studies with isolated mitochondria and rat hepatocytes. Molecular Pharmacology 1995, 48:825-834.
14. Harman D. Free radical involvement in ageing. Pathophysiology and therapeutic implications. Drugs & Aging 1993, 3:60-80.
15. Hensley K., Robinson K.A., Gabbita S.P., Salsman S., Floyd R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radical Biology and Medicine 2000, 28:1456-1462.
16. Hernandez-Diaz G., Alexander-Aguilera A., Arzaba-Villalba A., Soto-Rodriguez I., Garcia H.S. Effect of conjugated linoleic acid on body fat, tumor necrosis factor alpha. Prostaglandins, Leukotrienes and Essential Fatty Acids 2010, 82:105-109.
17. Hübscher S.G. Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006, 49:450-465.
18. Johansson L., Hakan L.A. A Spectrophotometric method for determination of catalase activity in small tissue samples. Analytical Biochemistry 1988, 174:331-336.
19. Jou J., Choi S.S., Diehl A.M. Mechanisms of disease progression in nonalcoholic fatty liver disease. Seminars in Liver Disease 2008, 28:370-379.
20. Kabuto H., Hasuike S., Minagawa N., Shishibori T. Effects of bisphenol A on the metabolism of active oxygen species in mouse tissue. Environmental Research 2003, 93:31-35.
21. Kohl C., Morgan P., Gescher A. Metabolism of genotoxicant 2-nitropropane to a nitric oxide species. Chemico-Biological Interactions 1995, 97:175-184.
22. Kosugi H., Kikugawa K. Potential thiobarbituric acid-reactive substances in peroxidized lipids. Free Radical Biology and Medicine 1989, 7:205-207.
23. Ludwig J., Viggiano T.R., McGrill D.B. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings 1980, 55:434-438.
24. McCord J.M., Fridovich I. Superoxide dismutase: An enzymic function for erythrocuprein (hemocuprein). Journal of Biological Chemistry 1969, 244:6049-6055.
25. Milner J.A. Functional foods and health promotion. Journal of Nutrition 1999, 129:1395S-1397S.
26. Moloney F., Toomey S., Noone E., Nugent A., Allan B., Loscher C.E., et al. Antidiabetic Effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes 2007, 56:574-582.
27. Nahmias, P. (2008). Trends in the prevalence of overweight among women in Egypt. PAA conference New Orleans, USA.
28. Natarajan S.K., Eapen C.E., Pullimood A.B., Balasubramanian K.A. Oxidative Stress in experimental liver microvesicular steatosis: Role of mitochondria and peroxisomes. Journal of Gastroenterology and Hepatology 2006, 21:1240-1249.
29. National Research Council Guide for the care and use of laboratory animals 1985, publication no. 85-23 (revised), National Institutes of Health, Bethesda, MD.
30. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine 1967, 70:158-169.
31. Pariza M.W. Perspective on the safety and effectiveness of conjugated linoleic acid. American Journal of Clinical Nutrition 2004, 79:1132S-1136S.
32. Park Y., Pariza M.W. Mechanisms of body fat modulation by conjugated linoleic acid (CLA). Food Research International 2007, 40:311-323.
33. Reitman S., Frankel S. A colorimetric method for the determination of serum GOT and GTP. American Journal of Clinical Pathology 1957, 28:55-63.
34. Robino G., Parola M., Marra F., Caligiuri A., De Franco R.M., Zamara E., et al. Interaction between 4-hydroxy-2,3-alkenals and the platelet-derived growth factor-beta receptor -Reduced tyrosine phosphorylation and downstream signaling in hepatic stellate cells. Journal of Biological Chemistry 2000, 275:40561-40567.
35. Schwimmer J.B., Deutsch R., Rouch J.B., Behling C., Newbury R., Lavine J.J. Obesity, insulin resistance and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. Journal of Pediatrics 2003, 143:500-505.
36. Soto-Rodriguez I., Pulido-Camarillo E., Hernandez-Diaz G., Alexander-Aguilera A., Garcia H.S. A CLA enriched diet improves organ damage associated with the metabolic syndrome in spontaneous hypertensive rats. Grasas y Aceites 2011, 62:49-54.
37. Spolarics Z., Meyenhofer M. Augmented resistance to oxidative stress in fatty rat livers induced by a short-term sucrose-rich diet. Biochimica et Biophysica Acta 2000, 1847:190-200.
38. Steinhart H., Rickert R., Winkler K. Identification and analysis of conjugated linoleic acid isomers (CLA). European Journal of Medical Research 2003, 8:370-372.
39. Valdecantos M.P., Perez-Matute P., Martínez J.A. Obesity and oxidative stress: Role of antioxidant supplementation. Revista de Investigación Clínica 2009, 61:127-139.
40. Weltman M.D., Farrell G.C., Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996, 111:1645-1653.
41. Yu B.P. Cellular defenses against damage reactive oxygen species. Physiological Reviews 1994, 74:139-162.